 | Up a level |
2018
Pflug, N., Chakupurakal, G., Theurich, S., Holtick, U., Leitzke, S., Chemnitz, J., Scheid, C., Hallek, M. and von Bergwelt-Baildon, M. (2018). Addition of rituximab to nonmyeloablative allogeneic transplantation for CLL and Richter's transformation - a single center experience. Oncol. Res. Treat., 41. S. 102 - 103. BASEL: KARGER. ISSN 2296-5262
2016
Holtick, U., Herling, M., Pflug, N., Chakupurakal, G., Leitzke, S., Wolf, D., Hallek, M., Scheid, C. and Chemnitz, J. (2016). Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol containing treosulfan in an elderly population with AML. Bone Marrow Transplant., 51. S. S442 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
2015
Chakupurakal, G., Garcia-Marquez, M., Shimabukuro vorn-hagen, A., Schloesser, H., Holtick, U., Scheid, C. and von Bergwelt-Baildon, M. (2015). Changes in T and B- cells in steroid refractory GvHD patients following treatment with a CD25-antibody. Bone Marrow Transplant., 50. S. S177 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Chakupurakal, G., Garcia-Marquez, M., Shimabukuro vorn-hagen, A., Schloesser, H., Holtick, U., Scheid, C. and von Bergwelt-Baildon, M. (2015). Changes in T and B- cells in steroid refractory GvHD patients following treatment with a CD25-antibody. Bone Marrow Transplant., 50. S. S177 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Chakupurakal, G., Garcia-Marquez, M., Shimabukuro-Vorn-hagen, A., Theurichi, S., Scheid, C., Hallek, M., Holtick, U. and von Bergwelt-Baildon, M. (2015). IL-10 producing B-10 cells can be identified as early as 30 days post an allogeneic stem cell transplant and are enriched in the transitional B-cell compartment. Bone Marrow Transplant., 50. S. S176 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Chakupurakal, G., Garcia-Marquez, M., Shimabukuro-Vorn-hagen, A., Theurichi, S., Scheid, C., Hallek, M., Holtick, U. and von Bergwelt-Baildon, M. (2015). IL-10 producing B-10 cells can be identified as early as 30 days post an allogeneic stem cell transplant and are enriched in the transitional B-cell compartment. Bone Marrow Transplant., 50. S. S176 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Chakupurakal, G., Leitzke, S., Langerbeins, P., Schiller, J., Schneider, P. M., Holtick, U., Shimabukuro-Vornhagen, A., Theurich, S., Chemnitz, J., Hallek, M., von Bergwelt-Baildon, M. and Scheid, C. (2015). Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality-a single institution experience. Ann. Hematol., 94 (10). S. 1717 - 1726. NEW YORK: SPRINGER. ISSN 1432-0584
Holtick, U., Shimabukuro-Vornhagen, A., Chakupurakal, G., Theurich, S., Leitzke, S., Wolf, D., Hallek, M., von Bergwelt-Baildon, M., Scheid, C. and Chemnitz, J. (2015). FLAMSA reduced-intensity regimen in high-risk AML patients - role of re-induction and disease state prior to transplant. Bone Marrow Transplant., 50. S. S443 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Holtick, U., Shimabukuro-Vornhagen, A., Chakupurakal, G., Theurich, S., Leitzke, S., Wolf, D., Hallek, M., von Bergwelt-Baildon, M., Scheid, C. and Chemnitz, J. (2015). FLAMSA reduced-intensity regimen in high-risk AML patients - role of re-induction and disease state prior to transplant. Bone Marrow Transplant., 50. S. S443 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365